FM
Frazier Management Portfolio holdings
AUM
$1.12M
This Quarter Return
+2.02%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
–
AUM
$882M
AUM Growth
+$882M
(+48%)
Cap. Flow
+$330M
Cap. Flow
% of AUM
37.37%
Top 10 Holdings %
Top 10 Hldgs %
91.23%
Holding
26
New
6
Increased
1
Reduced
4
Closed
1
Top Buys
| 1 |
Arcutis Biotherapeutics
ARQT
|
$314M |
| 2 |
Passage Bio
PASG
|
$78.9M |
| 3 |
Syndax Pharmaceuticals
SNDX
|
$10.9M |
| 4 |
Adverum Biotechnologies
ADVM
|
$9.87M |
| 5 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$9.55M |
Top Sells
| 1 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$77.7M |
| 2 |
Collegium Pharmaceutical
COLL
|
$15.4M |
| 3 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$4.46M |
| 4 |
ETTX
Entasis Therapeutics Holdings Inc.
ETTX
|
$793K |
| 5 |
Kezar Life Sciences
KZR
|
$363K |
Sector Composition
| 1 | Healthcare | 98.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Kezar Life Sciences
KZR
$28.9M
| – | – | -90,578 | Closed | -$363K |
|